ArticleJournal of neurogastroenterology and motility2013
Recent advances in the pathophysiology and treatment of gastroparesis.
Article in Journal of neurogastroenterology and motility, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 62 citations in OpenAlex.
- Role of balloon dilation test in identifying suitable candidates for gastric peroral endoscopic myotomy.DEN open · 2025Article
- Effects of DA-9701 (motilitone®) on gastric emptying, glycemic control, and oxidative stress in diabetic rats.PloS one · 2025Article
- The presentation of two rare idiopathic diseases in one patient: spontaneous idiopathic pneumoperitoneum and idiopathic gastroparesis: a case report.Annals of medicine and surgery (2012) · 2024Article
- The Association between Hormone Replacement Therapy and Gastroparesis in Post-Menopausal Women: A Worldwide Database Analysis.Journal of personalized medicine · 2024Article
- Long-term outcomes (≥3 years) after gastric peroral endoscopic myotomy for refractory gastroparesis: a systematic review and meta-analysis.iGIE : innovation, investigation and insights · 2023Article
- Review
- Nitric Oxide: From Gastric Motility to Gastric Dysmotility.International journal of molecular sciences · 2021Review
- A Comprehensive Review and Update of Post-surgical Cutaneous Nerve Entrapment.Current pain and headache reports · 2021Review
- Improvement in Symptomatic Gastroparesis With Increased Vagal Nerve Stimulation.Neurology. Clinical practice · 2021Article
- Serial Measurements of Refractive Index, Glucose and Protein to Assess Gastric Liquid Nutrient Transport-A Proof-of-Principal Study.Frontiers in nutrition · 2021Article
- Peroral endoscopic pyloromyotomy for gastroparesis: a systematic review and meta-analysis.Endoscopy international open · 2020Review
- Impact of Cannabinoids on Symptoms of Refractory Gastroparesis: A Single-center Experience.Cureus · 2019Article
- Effects of ajmaline on contraction patterns of isolated rat gastric antrum and portal vein smooth muscle strips and on neurogenic relaxations of gastric fundus.Pflugers Archiv : European journal of physiology · 2019Article
- Gender differences in the regulation of MLCBiomedical reports · 2018Article
- Gastric Peroral Endoscopic Myotomy (G-POEM) as a Treatment for Refractory Gastroparesis: Long-Term Outcomes.Canadian journal of gastroenterology & hepatology · 2018Article
- Gastric Peroral Endoscopic Pyloromyotomy Therapy for Refractory Gastroparesis.Current treatment options in gastroenterology · 2017Review
- Gastroparesis Updates on Pathogenesis and Management.Gut and liver · 2017Review
- Taste and Smell Disturbances in Patients with Gastroparesis and Gastroesophageal Reflux Disease.Journal of neurogastroenterology and motility · 2017Article
- Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study.Journal of neurogastroenterology and motility · 2016Article
- Effect of electroacupuncture on gastric interstitial cells of Cajal in a rat model of diabetic gastroparesis.Experimental and therapeutic medicine · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
Abstract
Gastroparesis is a clinical disorder characterized by upper gastrointestinal symptoms related with delayed gastric emptying of solids and liquids in the absence of mechanical obstruction. Diabetes mellitus has been the most common cause of gastroparesis and idiopathic gastroparesis also accounts for a third of all chronic cases. The most important mechanisms of gastroparesis, as understood to date, are loss of expression of neuronal nitric oxide synthase and loss of the interstitial cells of Cajal. However, the pathogenesis of gastroparesis is poorly understood. There have been several studies on specific molecules related to the pathogenesis of gastroparesis. Additionally, the Gastroparesis Clinical Research Consortium of the National Institutes of Health has achieved several promising results regarding the pathophysiology of gastroparesis. As the progress in the pathophysiology of gastroparesis has been made, a promising new drug therapy has been found. The pathophysiology and drug therapy of gastroparesis are focused in this review. Until now, the real-world medication options for treatment of gastroparesis are limited. However, it is expected to be substantially improved as the pathophysiology of gastroparesis is elucidated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.